News Archive

Events for the below selected month

Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach

Posted

29 March 2019

From the British Journal of Cancer

Background TNM8 staging for oropharyngeal squamous cell carcinomas (OPSCC) surrogates p16 immunohistochemistry for HPV testing. Patients with p16+ OPSCC may lack HPV aetiology. Here, we evaluate the suitability of TNM8 staging for guiding...

Summary of the European public assessment report (EPAR) for Erbitux

Posted

29 March 2019

European Medicines Agency

This is a summary of the European public assessment report (EPAR) for Erbitux. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and...

Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cance

Posted

29 March 2019

Case report from the United States

Methods We reviewed current statistics and the medical and legal literature regarding inbound medical tourism and the process of obtaining a visa for patients traveling to the United States for medical treatment. To illustrate this process, we...

Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma

Posted

15 March 2019

Scientific Report

Recently, exosomes secreted by menstrual mesenchymal stem cells have been identified as inhibitory agents of tumor angiogenesis and modulators of the tumor cell secretome in prostate and breast cancer. However, their direct effect on endothelial...

Bill introduced to make oral cancer medication more affordable

Posted

15 March 2019

News from America

WASHINGTON, D.C. — There’s a new effort on Capitol Hill to make newer cancer treatment options more affordable. U.S. Senator Tina Smith (D-Minnesota) along with U.S. Senator Jerry Moran (R-Kansas) re-introduced the “Cancer Drug Parity Act”...

The NKG2A immune checkpoint

Posted

15 March 2019

A new direction in cancer immunotherapy

Inhibition of the NKG2A immune checkpoint restores natural killer cell and T cell effector function in preclinical cancer models. In addition, NKG2A blockade in combination with other therapeutic antibodies is showing encouraging responses in a...

Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy

Posted

15 March 2019

Hopes for earlier diagnosis and better survival outcome in patients with head and neck cancer.

Patients with head and neck squamous cell carcinoma are at increased risk of developing a second primary malignancy, which is associated with poor prognosis and early death. To help improve clinical outcome, we aimed to identify biomarkers for...

Depiction of Oral Tumor-Induced Trigeminal Afferent Responses Using Single-Fiber Electrophysiology

Posted

15 March 2019

Considerable gap in knowledge exists about the mechanisms by which oral tumors regulate peripheral sensory fibers to produce pain and altered sensations. To address this gap, we used a murine model of oral squamous cell carcinoma (OSCC) of the...

BAHNO Research Grants

Posted

04 March 2019

Two awards given this year

BAHNO is pleased to announce that, due to the high standard of applications, the Research Committee has decided to make two awards this year. The recipients are: Paula Bradley (University of Sunderland) - who will receive £3,000 to develop...

Pool of Funding Released: Women’s Leadership Development

Posted

27 February 2019

Funding of up to £1,000 for surgery sector women available

Women & Leadership International is administering a national initiative to support the development of female leaders across the UK’s surgery sector. The campaign is providing women with grants of up to £1,000 to enable participation in a...

New cases of mouth cancer in the UK have now reached 8,302 a year

Posted

08 February 2019

The State of Mouth Cancer UK Report 2018/2019

This report is now available on the Oral Health Foundation website. A summary of the key findings: New cases of mouth cancer in the UK have now reached 8,302 a year. This has increased by 49% in the last decade and by 135% compared with...

Head and Neck Cancer UK

Posted

03 February 2019

HANCUK

The website for this charity is up and running: hancuk.org. This is a charity that is advocating for patients and their carers, raising awareness and providing information to patients and survivors of Head and Neck cancer in the UK.

LiTEFORM Trial

Posted

01 February 2019

News from Newcastle upon Tyne

LiTEFORM is a Randomised Controlled Trial of the Clinical and Cost Effectiveness of Low Level Laser in the Management of Oral Mucositis in Head and Neck Cancer Irradiation Please visit the LiTEFORM website to find out what LiTEFORM is, where it...

Vegetable intake and head and neck cancer survival are modestly associated

Posted

01 February 2019

Dietary behaviors and survival in people with head and neck cancer

This is an article from the NCBI in the United States Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000. BACKGROUND: The association between diet and head and neck cancer (HNC)...

De-intensified treatment in human papillomavirus-positive oropharyngeal cancer

Posted

01 February 2019

Article in The Lancet

This article by Johannes Christiaan Oosthuizen and Jaime Doody may be viewed in full here.

Cancer patients in poor countries needlessly denied pain relief

Posted

01 February 2019

WHO report

Cancer patients in developing nations are being denied basic pain relief, often because of excessive fears about opioid abuse, the World Health Organisation (WHO) said on Thursday. Two-thirds of industrialized countries have oral morphine, an...

BAHNO International Collaboration Committee

Posted

28 January 2019

New Director and members announced by President

I am very pleased to announce that Dr Mehmet Sen, Consultant Oncologist, Leeds, will be taking over as Chair of the International Committee. Mehmet has long experience and expertise in the management of head and neck cancer, and has been...

Head & Neck TIG recruitment round

Posted

28 January 2019

Advert now live

The advert for the upcoming Head & Neck TIG recruitment round is now live on the Severn website.

Study suggests non-steroidal anti-inflammatory drugs such as aspirin may help some patients survive head and neck cancer

Posted

26 January 2019

Study in the Journal of Experimental Medicine

PIK3CA is the most commonly altered oncogene in head and neck squamous cell carcinoma (HNSCC). We evaluated the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on survival in a PIK3CA-characterized cohort of 266 HNSCC patients and explored...

Thousands of girls did not get full HPV vaccine

Posted

25 January 2019

TWO doses required

It has emerged that one in three girls in some parts of the UK did not have their full vaccination at school against HPV, the virus that can cause cervical cancer, in 2017-18. While the national target of immunising 80% of girls is being met, the...

Back to News Home